Global X Genomics & Biotechnolo (NASDAQ:GNOM)

Complete Genomics, Inc., a life sciences company, develops and commercializes a DNA sequencing platform for human genome sequencing and analysis. Its Complete Genomics Analysis platform combines its proprietary human genome sequencing technology with informatics and data management software to provide customers with data that is ready to be used for genome-based research. The company’s human genome sequencing services are used in various applications, including cancer research, Mendelian disease research, rare variant disease research, translational research, clinical trial optimization, and companion diagnostic discovery. It serves academic research centers, government research centers, biopharmaceutical companies, and healthcare providers. The company was founded in 2005 and is headquartered in Mountain View, California.